Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-21

FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for zolpidem tartrate (Sandoz Inc) under ANDA 090107. The snippet does not specify the exact change, but it indicates ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate (zolpidem tartrate)

Snippet

SUPPL AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)